$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Cyclodextrin complexation 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-047/48
  • A61K-031/735
  • C08B-037/16
출원번호 US-0240510 (1994-05-11)
우선권정보 EP-0305280 (1993-07-06)
발명자 / 주소
  • Loftsson Thorsteinn (Reykjavik ISX)
출원인 / 주소
  • Cyclops h.f. (Reykjavik ISX 03)
인용정보 피인용 횟수 : 88  인용 특허 : 0

초록

The invention provides a method for enhancing the complexation of a cyclodextrin with a lipophilic and/or water-labile active ingredient which is a drug, cosmetic additive, food additive or agrochemical, comprising combining from about 0.1 to about 70% (weight/volume) of a cyclodextrin, from about 0

대표청구항

A method for enhancing the complexation of cyclodextrin with a lipophilic and/or water-labile active ingredient which is a drag, cosmetic additive, food additive or agrochemical, said method comprising combining from about 0.1 to about 70% (weight/volume) of cyclodextrin, from about 0.001 to about 5

이 특허를 인용한 특허 (88)

  1. Niitsu, Yoshiro, Agent for treating myelofibrosis.
  2. Antle, Vincent D.; Lopes, Alvaro; Monteiro, Daniel, Alkylated cyclodextrin compositions and processes for preparing and using the same.
  3. Antle, Vincent D.; Lopes, Álvaro; Monteiro, Daniel, Alkylated cyclodextrin compositions and processes for preparing and using the same.
  4. Penkler,Lawrence John, Alprazolam inclusion complexes and pharmaceutical compositions thereof.
  5. Kieran, Peter John; Lau, Kai Kin; Patten, Barry Edward, Anaesthetic composition.
  6. Kieran, Peter John; Lau, Kai Kin; Patten, Barry Edward, Anaesthetic composition.
  7. Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic compositions and methods of use.
  8. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  9. Brooks, JoAnn Adele, Anti-fungal powder having enhanced excipient properties.
  10. Chang,Yunik; Dow,Gordon J., Aqueous compositions containing metronidazole.
  11. Sandanayaka, Vincent; Singh, Jasbir; Sullins, David; Gurney, Mark E., Aryl amino acid derivatives as inhibitors for treating inflammation.
  12. Li,Jun; Li,Xu; Ni,Xiping; Leong,Kam W., Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from.
  13. Kosti, Carl M., Bleach stable toothpaste.
  14. Peter, David Wayne; Stanek, John Dillon; Orozco, Cheria L.; Gupta, Shyam K., Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion.
  15. Moldenhauer Jens-Peter,DEX ; Regiert Marlies,DEX ; Wimmer Thomas,DEX, Complexes of gamma-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use.
  16. Laszlo Darko, Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt.
  17. Jordan, Thomas A.; Chabala, John Clifford; Cagle, Gerald D., Compositions and methods for the treatment of macular degeneration.
  18. Jordan, Thomas A.; Dowling, John E.; Chabala, John Clifford, Compositions and methods of treating retinal disease.
  19. Backensfeld, Thomas; Heil, Wolfgang; Lipp, Ralph, Compositions of estrogen-cyclodextrin complexes.
  20. Pitha, Josef, Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds.
  21. Loftsson, Thorsteinn; Masson, Mar; Stefansson, Einar, Cyclodextrin complexes of benzodiazepines.
  22. Hayward James A. ; Maioriello James ; Ceccoli Joseph D., Cyclodextrin derivative complex.
  23. Loftsson, Thorsteinn; Stefansson, Einar, Cyclodextrin nanotechnology for ophthalmic drug delivery.
  24. Loftsson, Thorsteinn; Stefansson, Einar, Cyclodextrin nanotechnology for ophthalmic drug delivery.
  25. Loftsson, Thorsteinn; Stefánsson, Einar, Cyclodextrin nanotechnology for ophthalmic drug delivery.
  26. Pipkin, James D.; Mosher, Gerold L.; Hecker, Douglas B., DPI formulation containing sulfoalkyl ether cyclodextrin.
  27. Niitsu, Yoshiro; Kato, Junji; Sato, Yasushi, Drug carrier and drug carrier kit for inhibiting fibrosis.
  28. Niitsu, Yoshiro; Kato, Junji; Sato, Yasushi, Drug carrier and drug carrier kit for inhibiting fibrosis.
  29. Niitsu, Yoshiro; Yu, Lei; Liu, Jian; Zhao, Gang; Ma, Nianchun; Van, Sang, Drug carriers.
  30. Chang,Rong Kun, Drug formulation and delivery using crystalline methylated cyclodextrins.
  31. Qi, Helena; Remmert, Mike; Shieh, Wen; Hedges, Allan, Dry, edible oil and starch composition.
  32. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  33. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  34. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  35. Mosher, Gerold L.; Wedel, Rebecca L.; Johnson, Karen T.; Machatha, Stephen G.; Cowee, Jane A.; Cushing, Daniel J., Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use.
  36. Yunik Chang ; Gordon J. Dow ; Arturo Angel, Gel compositions containing metronidazole.
  37. Gamache, Daniel A.; Alani, Laman; Ghosh, Malay; Galan, Francisco Javier; Perdiguer, Nuria Carreras; Singh, Onkar N., High concentration olopatadine ophthalmic composition.
  38. Gamache, Daniel A.; Alani, Laman; Ghosh, Malay; Galán, Francisco Javier; Perdiguer, Núria Carreras; Singh, Onkar N., High concentration olopatadine ophthalmic composition.
  39. Pipkin, James D.; Zimmerer, Rupert O.; Thompson, Diane O.; Mosher, Gerold L., Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid.
  40. Pipkin, James D.; Zimmerer, Rupert O.; Thompson, Diane O.; Mosher, Gerold L., Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid.
  41. Pipkin, James D.; Zimmerer, Rupert O.; Thompson, Diane O.; Mosher, Gerold L., Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid.
  42. Lyons, Robert T.; Chang, James N., Inhibition of irritating side effects associated with use of a topical ophthalmic medication.
  43. Li, Jun; Yu, Hanry; Leong, Kam, Injectable drug delivery systems with cyclodextrin-polymer based hydrogels.
  44. Antle, Vincent D.; Matos, Jose R., Manufacturing process for cyclodextrin derivatives.
  45. Ishihara, Hiroshi; Takeda, Susumu; Yamada, Tomonari; Asahi, Yoshiaki, Method for stabilizing macrolide compounds.
  46. Shastri, Venkatram R.; Yue, Isaac; Hildgen, Patrice; Sinisterra, Ruben Dario; Langer, Robert, Method of increasing the efficacy of antibiotics by compexing with cyclodextrins.
  47. Terenetska, Iryna P.; Orlova, Tetiana M.; Kirilenko, Eugene K.; Galich, Grygory A; Eremneko, Anna M., Methods and devices for in situ determination of a vitamin-D synthesizing amount of natural and artificial UV irradiation.
  48. Loftsson,Thorsteinn, Non-inclusion cyclodextrin complexes.
  49. Jordan, Thomas A.; Chabala, John Clifford; Ling, Ke-Qing; Kinney, William A., Peri-carbinols.
  50. Marshall, Philip, Personalized health records with associative relationships.
  51. Marshall, Philip, Personalized health records with associative relationships.
  52. Penkler Lawrence J,ZAX ; Glintenkamp Lueta A,ZAX ; Nicholson Douglas G M,ZAX ; Van Oudtshoorn Michiel C B,ZAX, Pharmaceutical composition.
  53. Guitard Patrice,FRX ; Haeberlin Barbara,CHX ; Link Rainer,DEX ; Richter Friedrich,DEX, Pharmaceutical compositions.
  54. Guitard, Patrice; Haeberlin, Barbara; Link, Rainer; Richter, Friedrich, Pharmaceutical compositions.
  55. Lyons, Robert T.; Chang, James N.; Trogden, John T.; Whitcup, Scott, Pharmaceutical compositions.
  56. Guitard, Patrice; Haeberlin, Barbara; Link, Rainer; Richter, Friedrich, Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions.
  57. Mosher, Gerold L.; Machatha, Stephen G.; Cushing, Daniel J., Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same.
  58. Mosher, Gerold L.; Machatha, Stephen G.; Cushing, Daniel J., Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same.
  59. Mosher, Gerold L; Machatha, Stephen G.; Cushing, Daniel J., Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same.
  60. Judice, J. Kevin; Shaw, Jeng Pyng; Mu, YongQi; Conner, Michael W.; Pace, John L., Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin.
  61. Judice, J. Kevin; Shaw, Jeng-Pyng; Mu, YongQi; Conner, Michael W.; Pace, John L., Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin.
  62. Judice, J. Kevin; Shaw, Jeng-Pyng; Mu, YongQi; Conner, Michael W.; Pace, John L., Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin.
  63. Judice,J. Kevin; Shaw,Jeng Pyng; Mu,YongQi; Conner,Michael W.; Pace,John L., Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin.
  64. Judice,J. Kevin; Shaw,Jeng Pyng; Mu,YongQi; Conner,Michael W.; Pace,John L., Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin.
  65. Sandanayaka, Vincent; Chandrasekar, Pushpa; Gurney, Mark E., Phenoxymethylalkyne inhibitors of LTA4H for treating inflammation.
  66. Millán, Rubén Dario Sinisterra; Dos Santos, Robson Augusto Souza; Frezard, Fréderic Jean Georges; De Paula, Washington Xavier, Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications.
  67. Sharma, Vinay K., Preparation of micron-size pharmaceutical particles by microfluidization.
  68. Kleinfelter,William M., Prescription data processing system for determining new therapy starts.
  69. Sandanayaka, Vincent; Singh, Jasbir; Zhao, Lei; Yu, Peng; Gurney, Mark E., Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation.
  70. Kruse, Inge; Wolber, Rainer; Woeller, Karl-Heinz, Self-adhesive polymer matrix containing a seaweed extract.
  71. Woeller, Karl-Heinz; Berg, Thorsten; Kruse, Inge; Wolber, Rainer, Self-adhesive polymer matrix containing sea algae extract.
  72. Woeller, Karl-Heinz; Berg, Thorsten, Self-adhesive polymer matrix containing sea algae extract and glycerin.
  73. Kim, Nam Ho; Lee, Jin Young; Kim, Jae-Sun; Lee, Nam Kyu; Jang, Woo Jae; Oh, Joon Gyo; Lee, Yoon-Jung; Kim, Woong Sik; Sung, Jin-Heung; Um, Key An, Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same.
  74. Kipp, James E.; Wong, Joseph Chung Tak; Nair, Lakshmy; Miller, Reagan; Rabinow, Barrett E., Stable pharmaceutical formulations.
  75. Antle, Vincent D., Sulfoalkyl ether cyclodextrin compositions.
  76. Antle, Vincent D., Sulfoalkyl ether cyclodextrin compositions.
  77. Antle, Vincent D., Sulfoalkyl ether cyclodextrin compositions.
  78. Mosher, Gerold L.; Pipkin, James D.; Hecker, Douglas B., Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof.
  79. Pipkin, James D.; Mosher, Gerold L.; Hecker, Douglas B., Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof.
  80. Pipkin, James D.; Mosher, Gerold L.; Hecker, Douglas B., Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof.
  81. Pipkin, James D.; Mosher, Gerold L.; Hecker, Douglas B., Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof.
  82. Horn, Alan; Johnson, Ann Mond; Donlan, Joe; Heilman, Tracy; Fiacco, John, Systems, devices, and methods for providing healthcare information.
  83. Horn, Alan; Johnson, Ann Mond; Donlan, Joseph; Heilman, Tracy; Fiacco, John, Systems, devices, and methods for providing healthcare information.
  84. Niitsu, Yoshiro; Takimoto, Rishu, Targeting agent for cancer cell or cancer-associated fibroblast.
  85. Niitsu, Yoshiro; Takimoto, Rishu; Minomi, Kenjiro; Miyazaki, Miyono; Kajiwara, Keiko; Tanaka, Yasunobu, Therapeutic agent for pulmonary fibrosis.
  86. Marc Coles IL; Gad Keren IL, Topical carbamazepine formulations and methods of use.
  87. Brady, Todd; Young, Scott; Kinney, William A.; Mandell, Kenneth J., Toxic aldehyde related diseases and treatment.
  88. Chabala, John Clifford; Jordan, Thomas A.; Ling, Ke-Qing; Gleason, John G.; Kinney, William A., Traps in the treatment of macular degeneration.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로